BioSpace News Archive

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the launch of Medtronic Neurovascular Co-Lab™ Platform designed to accelerate urgently needed innovation in stroke care and treatment.

Dr. Jonathan Calkwood and his team at the Minnesota Center for Multiple Sclerosis have announced that, beginning January 2, 2023, they will be moving their practice from Golden Valley to City Center Professional Building at 15700 37th Ave North, Suite 110 in Plymouth, Minn.

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that research into the pharmacokinetics of an oral formulation of leuprolide (Ovarest®) utilizing Enteris’ proprietary Peptelligence® platform was highlighted in an oral presentation at the ASRM 2022 Scientific Congress & Expo in Anaheim, Calif.

Voltron Therapeutics, a Lucius Partners portfolio company, announced the company’s poster on its proprietary Self-Assembling Vaccine platform was selected for presentation and discussed at the Military Health System Research Symposium (MHSRS).

Dassault Systèmes and Sanofi announced their partnership to optimize “EVolutive Facility” production at Sanofi’s future state-of-the-art modular manufacturing facilities in France and Singapore.

Boehringer Ingelheim today announced that the first U.S. patient has enrolled in FIBRONEER™-IPF, a global Phase III trial evaluating BI 1015550, an investigational phosphodiesterase 4B (PDE4B) inhibitor, in people living with idiopathic pulmonary fibrosis (IPF).